Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Surendra Kumar Sahoo was just 27 years old when he discovered that he was suffering from end-stage renal disease, which meant ...

Chronic kidney disease can be a silent killer; thus, we need to know about the causes and symptoms of CKD in advance for ...

While the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

Guwahati: Physicians at Gauhati Medical College and Hospital (GMCH) have flagged elevated instances of Chronic Kidney Disease ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

The impact of chronic kidney disease (CKD) keeps escalating around the world, and this burden is projected to rise with ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and ...